 |
 |
|
• March 29 - April 1, 2008
ACC 2008 Annual Scientific Session
Chicago, IL USA
• March 31, 2008
International Competitive Grants Awards Program for Young
Investigators Awards Ceremony and Reception
Chicago, IL USA
• May 14 - 17, 2008
ASH 23rd Annual Scientific Meeting and Exposition
New Orleans, LA USA
• August 30 - Sept 03, 2008
ESC Congress 2008
Munich, Germany
• June 14 - 18, 2009
XV International Symposium On Atherosclerosis
Boston, MA USA
|
|
|
|
|
 |
| |
 |
|
|
|
|
March 27, 2003
GLAXOSMITHKLINE RESEARCH & EDUCATION FOUNDATION AWARDS YOUNG INVESTIGATORS WITH $400,000 IN GRANTS FOR INNOVATIVE CARDIOVASCULAR RESEARCH
The GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease today announced the winners of its research grants program. The
Competitive Grants Award Program for Young Investigators is a $400,000, two-year grant program enabling young investigators and advanced cardiovascular
disease fellows from all over the world to obtain funding for innovative research. The winners were honored at a reception held during the American College of
Cardiology annual meeting in Chicago, Illinois.*
AWARD RECIPIENTS TO CONDUCT CUTTING-EDGE RESEARCH
Dr. Lars Maier, Clinical Resident in Cardiology and Internal Medicine, Georg-August-Universität Göttingen, Göttingen, Germany plans to study the acute
and long-term effect of CaMKII overexpression on L-type Ca currents, intracellular Ca handling and heart failure. He will investigate whether increased CaMKII
expression levels contribute to the pathogenesis of heart failure or whether they are a protective means for the heart to ameliorate its contractile dysfunction. Dr.
Maier's research will be conducted in transatlantic cooperation between Loyola University in Chicago, Illinois, and the Georg-August-Universität Göttingen,
Göttingen, Germany.
Dr. Moussa Mansour, Assistant in Medicine, Massachusetts General Hospital, Boston; Instructor in Medicine, Harvard Medical School, has concentrated his
research on atrial fibrillation. Dr. Mansour will use a model of stretch-induced AF in the goat and utilize cardiac gene transfer technology to understand the role
of specific ion channels linking electrical events at the level of the membranes and the development of the arrhythmia. It is hoped his research will further
understanding of the mechanisms of atrial fibrillation and indicate new possibilities for the management of this widely prevalent disease.
Dr. Tomohisa Nagoshi, Research Fellow, Massachusetts General Hospital, Charlestown, will explore the role of Akt, an intracellular mediator of the
actions of insulin and IGF-1, in diabetic cardiomyopathy and the therapeutic potential of Akt activation in preventing this complication. If successful, his work
could lead to the development of novel therapeutic approaches to treating or preventing this major cause of morbidity and mortality in diabetes.
Dr. Joseph Wu, Cardiology Fellow, UCLA School of Medicine, was the 2002 recipient of the Society for Nuclear Medicine's First Prize Award for
Cardiovascular Young Investigators. He has researched noninvasive cardiac imaging of reporter gene expression using optical and positron emission tomography (PET)
imaging, and his work was featured in the July 2002 issue of Circulation. With his grant, Dr. Wu plans to focus on the molecular imaging of cardiac cell transplant
as an approach to quantifying the kinetics of cell survival and the development of screening protocols for potential therapeutic interventions to prolong cell
survival.
"We are very excited to be providing much needed resources to this outstanding group of young researchers," said Valentin Fuster, M.D., Ph.D., Director of the
Cardiovascular Institute and Health Center, Professor of Cardiology at the Mount Sinai Medical Center in New York, and Chairman of the GlaxoSmithKline Research and
Education Foundation for Cardiovascular Disease. "Unfortunately, there is a lack of adequate research funding, especially for younger scientists. Our mission is to
promote a new generation of clinician scientists by supporting the activities of promising researchers. Our hope is that by helping these clinicians in their
research of today that we are helping to devise the treatments of tomorrow."
FOUNDATION TO SPONSOR GENOMICS WORKSHOP
The Foundation was launched in November 2001. As part of its mission, the Foundation sponsors educational workshops on cutting-edge topics. Its second annual
symposium, Genomics and Cardiovascular Disease, will be held on May 30-31, 2003, in Philadelphia, PA. This state-of-the-art symposium will be led by
distinguished leaders in the field who will address a wide range of topics including biological issues in cardiovascular disease, traditional and non-traditional
risk factors, the role of genetic screening and the potential of gene therapy, and ethical issues in genomics and genetics.
More information is available at www.cvfoundation.org.
*This event is not part of the official American College of Cardiology (ACC) Annual Scientific Session as planned by the Annual Scientific
Session Program Committee (AASPC).
The GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease receives support through a grant from
GlaxoSmithKline.
|
|
|
|
Other Press Releases:
Press Kit entries feature recent and past press releases and other background information on the GlaxoSmithKline Research & Education Foundation for
Cardiovascular Disease.
The press releases posted on this site are intended for journalists.
|
|
 |
|
|
